245 related articles for article (PubMed ID: 33210582)
21. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
22. Targeted Drug Delivery in Brain Tumors-nanochemistry Applications and Advances.
Ganjeifar B; Morshed SF
Curr Top Med Chem; 2021 Oct; 21(14):1202-1223. PubMed ID: 33185163
[TBL] [Abstract][Full Text] [Related]
23. Theranostic application of nanoemulsions in chemotherapy.
Gorain B; Choudhury H; Nair AB; Dubey SK; Kesharwani P
Drug Discov Today; 2020 Jul; 25(7):1174-1188. PubMed ID: 32344042
[TBL] [Abstract][Full Text] [Related]
24. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
25. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives.
Zhang J; Wang L; You X; Xian T; Wu J; Pang J
Curr Top Med Chem; 2019; 19(1):57-73. PubMed ID: 30686255
[TBL] [Abstract][Full Text] [Related]
27. Biomedical application of graphene: From drug delivery, tumor therapy, to theranostics.
Song S; Shen H; Wang Y; Chu X; Xie J; Zhou N; Shen J
Colloids Surf B Biointerfaces; 2020 Jan; 185():110596. PubMed ID: 31707226
[TBL] [Abstract][Full Text] [Related]
28. Magnetic nanoparticles based cancer therapy: current status and applications.
Zhang H; Liu XL; Zhang YF; Gao F; Li GL; He Y; Peng ML; Fan HM
Sci China Life Sci; 2018 Apr; 61(4):400-414. PubMed ID: 29675551
[TBL] [Abstract][Full Text] [Related]
29. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
[TBL] [Abstract][Full Text] [Related]
30. Nanobiomaterials Used in Cancer Therapy: An Up-To-Date Overview.
Lungu II; Grumezescu AM; Volceanov A; Andronescu E
Molecules; 2019 Sep; 24(19):. PubMed ID: 31574993
[TBL] [Abstract][Full Text] [Related]
31. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
32. Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.
Varghese OP; Liu J; Sundaram K; Hilborn J; Oommen OP
Biomater Sci; 2016 Aug; 4(9):1310-3. PubMed ID: 27431007
[TBL] [Abstract][Full Text] [Related]
33. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
34. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
[TBL] [Abstract][Full Text] [Related]
35. A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected].
Wang H; Agarwal P; Zhao S; Yu J; Lu X; He X
Nat Commun; 2015 Dec; 6():10081. PubMed ID: 26621191
[TBL] [Abstract][Full Text] [Related]
36. Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics.
Jhaveri J; Raichura Z; Khan T; Momin M; Omri A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33430478
[TBL] [Abstract][Full Text] [Related]
37. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
Mohammadi M; Ramezani M; Abnous K; Alibolandi M
Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
[TBL] [Abstract][Full Text] [Related]
38. [Supramolecular Agents for Theranostics].
Deyev SM; Lebedenko EN
Bioorg Khim; 2015; 41(5):539-52. PubMed ID: 26762091
[TBL] [Abstract][Full Text] [Related]
39. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
[TBL] [Abstract][Full Text] [Related]
40. Research progress of novel inorganic nanometre materials carriers in nanomedicine for cancer diagnosis and treatment.
Xu J; Liao K; Jiang H; Zhou W
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S492-S502. PubMed ID: 30449177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]